In contrast to common obesity, where cardiovascular risk reduction drives intervention, the main rationale for treatment in MC4R -deficient patients shifts toward alleviating mechanical complications (e.g., sleep apnea, osteoarthritis), preventing diabetes (hyperinsulinemia is common despite relative euglycemia), and improving quality of life [30]
Some patients report that night-time dosing allows them to sleep through initial side effects, though there is no conclusive clinical evidence that timing categorically reduces nausea
Why The Results Differ From Previous Clinical Trials Earlier randomized trials including the STEP 1 extension for semaglutide and the SURMOUNT-4 trial for tirzepatide found that patients who stopped these medications regained a significant portion of their lost weight within a year
PlexusDx Compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan), ensuring you can maintain consistent access to your medication without dose-dependent price increases
At the end of the day, there is no single weight loss medication that works perfectly for everyone
-(1).png?sfvrsn=c236e848_3)
